Malaysia Stop Tyrosine Kinase Inhibitor Trial
NCT02381379
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
118
Enrollment
OTHER_GOV
Sponsor class
Conditions
Leukemia, Chronic Myeloid
Interventions
DRUG:
Peginterferon-α-2a
Sponsor
Ministry of Health, Malaysia